John Leonard, Director of the Center for Blood Cancers and Chief of the Division of Hematology and Medical Oncology at NYU Langone Health, shared a post on X:
“Leonard List number 6 ASH2025 top lymphoma abstracts – Abdelhakim et al abstract 1846: MT-601 in pts with R/R Hodgkin lymphoma – T cell construct vs 6 tumor-specific antigens, 7/9 patients with response, short follow up, well tol.”
More posts featuring John P. Leonard on OncoDaily.